Physical principles of microbubbles for ultrasound imaging and therapy

Cerebrovascular Diseases

Volumn 27, Issue SUPPL. 2, 2009, Pages 1-13

  Stride, Eleanor ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Contrast agents; Drug delivery; Gene therapy; High intensity focused ultrasound; Microbubbles; Sonothrombolysis

Indexed keywords

ALBUNEX; BISPHERE; ECHO CONTRAST MEDIUM; ECHOGENIC LIPOSOME; ECHOVIST; LIPOSOME; PERFLUOROPENTANE; PERFLUTREN; SHU 508; SONOVUE; SONOZOID; UNCLASSIFIED DRUG;

CHEMICAL ANALYSIS; COATED GAS MICROBUBBLE; EMULSION; HUMAN; IMAGE ENHANCEMENT; IMPEDANCE; MICROBUBBLE; OSCILLATION; PHASE SHIFT EMULSION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RADIATION RESPONSE; RADIUS; REVIEW; THERMAL ANALYSIS; ULTRASOUND;

CONTRAST MEDIA; EMULSIONS; FREE RADICALS; HOT TEMPERATURE; HUMANS; LIPOSOMES; MICROBUBBLES; THROMBOLYTIC THERAPY; ULTRASONOGRAPHY, DOPPLER;

EID: 65349141947     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000203122     Document Type: Review

References (104)

1. Al-Mansour HA, Mulvagh SL, Pumper GM, Klarich KW, Foley DA: Usefulness of harmonic imaging for left ventricular opacification and endocardial border delineation by Optison. Am J Cardiol 2000; 85: 795-799.
2. Strauss AL, Beller KD: Persistent opacification of the left ventricle and myocardium with a new echo contrast agent. Ultrasound Med Biol 1999; 25: 763-769.
3. Porter TR, Xie F, Kricsfeld A: The mechanism and clinical implication of improved left-ventricular videointensity following intravenous- injection of multi-fold dilutions of albumin with dextrose. Int J Card Imaging 1995; 11: 117-125.
4. Lindner JR, Wei K, Kaul S: Imaging of myocardial perfusion with SonoVue (TM) in patients with a prior myocardial infarction. Echocardiography 1999; 16: 753-760.
5. Caiati C, Aragona P, Iliceto S, Rizzon P: Improved Doppler detection of proximal left anterior descending coronary artery stenosis after intravenous injection of a lung-crossing contrast agent: a transesophageal Doppler echocardiographic study. J Am Coll Cardiol 1996; 27: 1413-1421.
6. Huang SF, Chang RF, Moon WK, Lee YH, Chen DR, Suri JS: Analysis of tumor vascularity using three-dimensional power Doppler ultrasound images. IEEE Trans Med Imaging 2008; 27: 320-330.
7. McDonald DM, Choyke PL: Imaging of angiogenesis: from microscope to clinic. Nat Med 2003; 9: 713-725.
8. Meairs S: Contrast-enhanced ultrasound perfusion imaging in acute stroke patients. Eur Neurol 2008; 59: 17-26.
9. Prefumo F, Serafini G, Martinoli C, Gandolfo N, Gandolfo NG, Derchi LE: The sonographic evaluation of tubal patency with stimulated acoustic emission imaging. Ultrasound Obstet Gynecol 2002; 20: 386-389.
10. Darge K, Moeller RT, Trusen A, Butter F, Gordjani N, Riedmiller H: Diagnosis of vesicoureteric reflux with low-dose contrast-enhanced harmonic ultrasound imaging. Pediatr Radiol 2005; 35: 73-78.
11. Bleeker H, Shung K, Barnhart J: On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion. J Ultrasound Med 1990; 9: 461- 471.
12. Leen E, Ceccotti P, Kalogeropoulou C, Angerson WJ, Moug SJ, Horgan PG: Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. Am J Roentgenol 2006; 186: 1551-1559.
13. Leen E, Ceccotti P, Moug SJ, et al: Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases - an essential investigation before resection? Ann Surg 2006; 243: 236-240.
14. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S: Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97: 473-483.
15. Lindner JR, Villanueva FS, Dent JM, Wei K, Sklenar J, Kaul S: Assessment of resting perfusion with myocardial contrast echocardiography: theoretical and practical considerations. Am Heart J 2000; 139: 231-240.
16. Stride E, Tang M, Eckersley RJ: Physical phenomena affecting quantitative imaging of ultrasound contrast agents. Appl Acoust 2008, DOI:10.1016/j. apacoust.2008.10.003.
17. Kaufmann BA, Lindner JR: Molecular imaging with targeted contrast ultrasound. Curr Opin Biotechnol 2007; 18: 11-16.
18. Schneider M: Molecular imaging and ultrasound- assisted drug delivery. J Endourol 2008; 22: 795-801.
19. Kaneko Y, Maruyama T, Takegami K, et al: Use of a microbubble agent to increase the effects of high intensity focused ultrasound on liver tissue. Eur Radiol 2005; 15: 1415-1420.
20. Luo W, Zhou XD, Ren XL, Zheng MJ, Zhang J, He GB: Enhancing effects of SonoVue, a microbubble sonographic contrast agent, on high-intensity focused ultrasound ablation in rabbit livers in vivo. J Ultrasound Med 2007; 26: 469-476.
21. Bull JL: The application of microbubbles for targeted drug delivery. Expert Opin Drug Deliv 2007; 4: 475-493.
22. Tartis MS, McCallan J, Lum AFH, et al: Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med Biol 2006; 32: 1771-1780.
23. Pichon C, Kaddur K, Midoux P, Tranquart F, Bouakaz A: Recent advances in gene delivery with ultrasound and microbubbles. J Exp Nanosci 2008; 3: 17-40.
24. van Wamel A, Kooiman K, Harteveld M, et al: Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release 2006; 112: 149-155.
25. Iwanaga K, Tominaga K, Yamamoto K, et al: Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther 2007; 14: 354-363.
26. Meairs S, Alonso A: Ultrasound, microbubbles and the blood-brain barrier. Prog Biophys Mol Biol 2007; 93: 354-362.
27. Molina CA, Ribo M, Rubiera M, et al: Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006; 37: 425-429.
28. Culp WC, Porter TR, Lowery J, Xie F, Roberson PK, Marky L: Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine. Stroke 2004; 35: 2407- 2411.
29. Becher H, Burns P: Handbook of Contrast Echocardiography. New York, Springer, 2008.
30. Quaia E: Contrast Media in Ultrasonography - Basic Principles and Clinical Applications. New York, Springer, 2005.
31. Feigenba H, Stone JM, Lee DA, Nasser WK, Chang S: Identification of ultrasound echoes from left ventricle by use of intracardiac injections of indocyanine green. Circulation 1970; 41: 615-621.
32. Gramiak R, Shah PM: Echocardiography of the aortic root. Invest Radiol 1968; 3: 356- 366.
33. Kremkau FW, Gramiak R, Carstens EL, Shah PM, Kramer DH: Ultrasonic detection of cavitation at catheter tips. Am J Roentgenol Radium Ther Nucl Med 1970; 110: 177-183.
34. Feinstein SB, Tencate FJ, Zwehl W, et al: Two-dimensional contrast echocardiography. 1. In vitro development and quantitative- analysis of echo contrast agents. J Am Coll Cardiol 1984; 3: 14-20.
35. Bauer A, Blomley M, Leen E, Cosgrove D, Schlief R: Liver-specific imaging with SHU 563A: Diagnostic potential of a new class of ultrasound contrast media. Eur Radiol 1999; 9:S349-S352.
36. Albrecht T, Hoffmann CW, Wolf KJ: Ultrasound diagnosis of liver metastases with liver- specific contrast media. Radiologe 2001; 41: 8-15.
37. Rapoport N, Gao ZG, Kennedy A: Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 2007; 99: 1095-1106.
38. Tran TD, Caruthers SD, Hughes M, et al: Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. Int J Nanomed 2007; 2: 515-526.
39. Oeffinger BE, Wheatley MA: Development and characterization of a nano-scale contrast agent. Ultrasonics 2004; 42: 343-347.
40. Huang SL: Liposomes in ultrasonic drug and gene delivery. Adv Drug Deliv Rev 2008; 60: 1167-1176.
41. Tiukinhoy SD, Khan AA, Huang SL, Klegerman ME, MacDonald RC, McPherson DD: Novel echogenic drug-immunoliposomes for drug delivery. Investigative Radiology 2004; 39: 104-110.
42. Smith DAB, Porter TM, Martinez J, et al: Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound. Ultrasound in Medicine and Biology 2007; 33: 797- 809.
43. Coussios CC, Holland CK, Jakubowska L, et al: In vitro characterization of liposomes and Optison (R) by acoustic scattering at 3.5 MHz. Ultrasound Med Biol 2004; 30: 181-190.
44. Hamilton A, Rabbat M, Jain P, et al: A physiologic flow chamber model to define intravascular ultrasound enhancement of fibrin using echogenic liposomes. Invest Radiol 2002; 37: 215-221.
45. Lindner JR: Detection of inflamed plaques with contrast ultrasound. Am J Cardiol 2002; 90: 32L-35L.
46. Lindner JR, Song J, Xu F, et al: Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 2000; 102: 2745-2750.
47. Leong-Poi H, Christiansen J, Klibanov AL, Kaul S, Lindner JR: Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation 2003; 107: 455-460.
48. Weller GER, Villanueva FS, Tom EM, Wagner WR: Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewis. Biotechnol Bioeng 2005; 92: 780-788.
49. Takalkar AM, Klibanov AL, Rychak JJ, Lindner JR, Ley K: Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release 2004; 96: 473-482.
50. Klibanov AL: Microbubble contrast agents - targeted ultrasound imaging and ultrasound- assisted drug-delivery applications. Invest Radiol 2006; 41: 354-362.
51. Stride E, Porter C, Prieto A, Pankhurst Q: Enhancement of microbubble mediated gene delivery by simultaneous exposure to ultrasonic and magnetic fields. Ultrasound Med Biol 2008; 123: 3217.
52. Stride E, Pancholi K, Edirisinghe MJ, Samarasinghe S: Increasing the nonlinear character of microbubble oscillations at low acoustic pressures. J R Soc Interface 2008; 5: 807-811.
53. Kheirolomoom A, Dayton PA, Lum AFH, et al: Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J Control Release 2007; 118: 275-284.
54. Ferrara K, Pollard R, Borden M: Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 2007; 9: 415-447.
55. Yang XM, Roy RA, Holt RG: Bubble dynamics and size distributions during focused ultrasound insonation. J Acoust Soc Am 2004; 116: 3423-3431.
56. Farny CH, Wu TM, Holt RG, Murray TW, Roy RA: Nucleating cavitation from laser-illuminated nano-particles. Acoust Res Lett Online-Arlo 2005; 6: 138-143.
57. Hoff L, Sontum PC, Hovem JM: Oscillations of polymeric microbubbles: effect of the encapsulating shell. J Acoust Soc Am 2000; 107: 2272-2280.
58. Chetty K, Stride E, Sennoga CA, Hajnal JV, Eckersley RJ: High-speed optical observations and simulation results of SonoVue microbubbles at low-pressure insonation. IEEE Trans Ultrason Ferroelectr Freq Control 2008; 55: 1333-1342.
59. Postema M, van Wamel A, Lancee CT, de Jong N: Ultrasound-induced encapsulated microbubble phenomena. Ultrasound Med Biol 2004; 30: 827-840.
60. de Jong N, Emmer M, Chin CT, et al: 'Compression- only' behavior of phospholipidcoated contrast bubbles. Ultrasound Med Biol 2007; 33: 653-656.
61. Emmer M, van Wamel A, Goertz DE, de Jong N: The onset of microbubble vibration. Ultrasound Med Biol 2007; 33: 941-949.
62. Bohmer MR, Schroeders R, Steenbakkers JAM, et al: Preparation of monodisperse polymer particles and capsules by ink-jet printing. Colloids Surf A Physicochem Eng Asp 2006; 289: 96-104.
63. Stride E, Saffari N: Investigating the significance of multiple scattering in ultrasound contrast agent particle populations. IEEE Trans Ultrason Ferroelectr Freq Control 2005; 52: 2332-2345.
64. Qin SP, Ferrara KW: Acoustic response of compliable microvessels containing ultrasound contrast agents. Phys Med Biol 2006; 51: 5065-5088.
65. Caskey CF, Stieger SM, Qin S, Dayton PA, Ferrara KW: Direct observations of ultrasound microbubble contrast agent interaction with the microvessel wall. J Acoust Soc Am 2007; 122: 1191-1200.
66. Flynn HG: Physics of acoustic cavitation. J Acoust Soc Am 1959; 31: 1582.
67. Chomas JE, Dayton P, Allen J, Morgan K, Ferrara KW: Mechanisms of contrast agent destruction. IEEE Trans Ultrason Ferroelectr Freq Control 2001; 48: 232-248.
68. Schrope B, Newhouse VL, Uhlendorf V: Simulated capillary blood-flow measurement using a nonlinear ultrasonic contrast agent. Ultrason Imaging 1992; 14: 134-158.
69. Forsberg F, Shi WT, Goldberg BB: Subharmonic imaging of contrast agents. Ultrasonics 2000; 38: 93-98.
70. Vannan MA, Burns PN, Hope-Simpson D, Averkiou M, Powers JE: Pulse inversion detection, an improved method for myocardial contrast echocardiography: experimental studies and preliminary clinical experience. Circulation 1998; 98: 503.
71. Eckersley RJ, Chin CT, Burns PN: Optimising phase and amplitude modulation schemes for imaging microbubble contrast agents at low acoustic power. Ultrasound Med Biol 2005; 31: 213-219.
72. Bouakaz A, Versluis M, Borsboom J, de Jong N: Radial modulation of microbubbles for ultrasound contrast imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2007; 54: 2283-2290.
73. Harvey CJ, Blomley MJK, Eckersley RJ, Heckemann RA, Butler-Barnes J, Cosgrove DO: Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet 2000; 355: 807-808.
74. Mornstein V: Cavitation-induced risks associated with contrast agents used in ultrasonography. Eur J Ultrasound 1997; 5: 101-111.
75. ter Haar GR: Ultrasonic contrast agents: safety considerations reviewed. Eur J Radiol 2002; 41: 217-221.
76. Nyborg W: WFUMB safety symposium on echo-contrast agents: mechanisms for the interaction of ultrasound. Ultrasound Med Biol 2007; 33: 224-232.
77. Hill CR, Bamber J, Ter Haar G: Physical Principles of Medical Ultrasound. Chichester, Ellis Horwood, 2004.
78. Dayton P, Klibanov A, Brandenburger G, Ferrara K: Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles. Ultrasound Med Biol 1999; 25: 1195- 1201.
79. Starritt HC, Duck FA, Humphrey VF: Forces acting in the direction of propagation in pulsed ultrasound fields. Phys Med Biol 1991; 36: 1465-1474.
80. Miller DL, Thomas RM, Williams AR: Mechanisms for hemolysis by ultrasonic cavitation in the rotating exposure system. Ultrasound Med Biol 1991; 17: 171-178.
81. Miller DL, Gies RA, Chrisler WB: Ultrasonically induced hemolysis at high cell and gas body concentrations in a thin-disc exposure chamber. Ultrasound Med Biol 1997; 23: 625- 633.
82. Miller DL, Nyborg WL, Whitcomb CC: Platelet-aggregation induced by ultrasound under specialized conditions in vitro. Science 1979; 205: 505-507.
83. Garbin V, Cojoc D, Ferrari E, et al: Changes in microbubble dynamics near a boundary revealed by combined optical micromanipulation and high-speed imaging. Appl Phys Lett 2007; 90: 114103.
84. Elder S, Nyborg WL: Acoustic streaming resulting from a resonant bubble. J Acoust Soc Am 1956; 28: 155.
85. Elder SA, Kolb J, Nyborg WL: Small-scale acoustic streaming effects in liquids. J Acoust Soc Am 1954; 26: 933.
86. Marmottant P, Hilgenfeldt S: Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 2003; 423: 153-156.
87. Marmottant P, Biben T, Hilgenfeldt S: Deformation and rupture of lipid vesicles in the strong shear flow generated by ultrasounddriven microbubbles. Proc Math Phys Eng Sci 2008; 464: 1781-1800.
88. Clarke PR, Hill CR: Physical and chemical aspects of ultrasonic disruption of cells. J Acoust Soc Am 1970; 47: 649-653.
89. Rooney JA: Hemolysis near an ultrasonically pulsating gas bubble. Science 1970; 169: 869-871.
90. Ward M, Wu JR, Chiu JF: Ultrasound-induced cell lysis and sonoporation enhanced by contrast agents. J Acoust Soc Am 1999; 105: 2951-2957.
91. Prokop AF, Soltani A, Roy RA: Cavitational mechanisms in ultrasound-accelerated fibrinolysis. Ultrasound Med Biol 2007; 33: 924-933.
92. Datta S, Coussios CC, McAdory LE, et al: Correlation of cavitation with ultrasound enhancement of thrombolysis. Ultrasound Med Biol 2006; 32: 1257-1267.
93. Prentice P, Cuschierp A, Dholakia K, Prausnitz M, Campbell P: Membrane disruption by optically controlled microbubble cavitation. Nat Phys 2005; 1: 107-110.
94. Wu J, Nyborg WL: Ultrasound, cavitation bubbles and their interaction with cells. Adv Drug Deliv Rev 2008; 60: 1103-1116.
95. Hilgenfeldt S, Lohse D, Zomack M: Sound scattering and localized heat deposition of pulse-driven microbubbles. J Acoust Soc Am 2000; 107: 3530-3539.
96. Coussios CC, Farny CH, Ter Haar G, Roy RA: Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focused ultrasound (HIFU). Int J Hypertherm 2007; 23: 105-120.
97. Hariharan P, Myers MR, Banerjee RK: HIFU procedures at moderate intensities - effect of large blood vessels. Phys Med Biol 2007; 52: 3493-3513.
98. Liu YB, Kon T, Li CY, Zhong P: High intensity focused ultrasound-induced gene activation in solid tumors. J Acoust Soc Am 2006; 120: 492-501.
99. Plathow C, Lohr F, Divkovic G, et al: Focal gene induction in the liver of rats by a heatinducible promoter using focused ultrasound hyperthermia - preliminary results. Invest Radiol 2005; 40: 729-735.
100. Noltingk BE, Neppiras EA: Cavitation produced by ultrasonics. Proc Phys Soc Lond B 1950; 63: 674-685.
101. Suslick KS: Sonochemistry. Science 1990; 247: 1439-1445.
102. Riesz P, Kondo T: Free-radical formation induced by ultrasound and its biological implications. Free Radic Biol Med 1992; 13: 247-270.
103. Mitragotri S: Innovation - healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov 2005; 4: 255-260.
104. Juffermans LJM, Kamp O, Dijkmans PA, Visser CA, Musters RJP: Low-intensity ultrasound- exposed microbubbles provoke local hyperpolarization of the cell membrane via activation of BKCa channels. Ultrasound Med Biol 2008; 34: 502-508.